Research and Development Expense

Name: Denali Therapeutics Inc. Research and Development Expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Denali Therapeutics Inc.·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	$116.23M	$102.7M	$101.95M	$97.91M	$103.85M
Total	$116.23M	$102.7M	$101.95M	$97.91M	$103.85M

Segments

Business SegmentsView metric